SE0100197L - Metod för diagnosticering av cancer i vävnad - Google Patents

Metod för diagnosticering av cancer i vävnad

Info

Publication number
SE0100197L
SE0100197L SE0100197A SE0100197A SE0100197L SE 0100197 L SE0100197 L SE 0100197L SE 0100197 A SE0100197 A SE 0100197A SE 0100197 A SE0100197 A SE 0100197A SE 0100197 L SE0100197 L SE 0100197L
Authority
SE
Sweden
Prior art keywords
cells
cyclin
protein
type
sample
Prior art date
Application number
SE0100197A
Other languages
Unknown language ( )
English (en)
Other versions
SE0100197D0 (sv
Inventor
Fredrik Erlandsson
Anders Zetterberg
Original Assignee
Fredrik Erlandsson
Anders Zetterberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fredrik Erlandsson, Anders Zetterberg filed Critical Fredrik Erlandsson
Priority to SE0100197A priority Critical patent/SE0100197L/sv
Publication of SE0100197D0 publication Critical patent/SE0100197D0/sv
Priority to CA002435210A priority patent/CA2435210A1/en
Priority to CNA028040597A priority patent/CN1502044A/zh
Priority to EP02716509A priority patent/EP1354210B1/en
Priority to JP2002559682A priority patent/JP2004529322A/ja
Priority to DE60216045T priority patent/DE60216045T2/de
Priority to AT02716509T priority patent/ATE345503T1/de
Priority to ES02716509T priority patent/ES2276922T3/es
Priority to US10/466,908 priority patent/US20040115746A1/en
Priority to PCT/SE2002/000116 priority patent/WO2002059616A1/en
Publication of SE0100197L publication Critical patent/SE0100197L/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SE0100197A 2001-01-24 2001-01-24 Metod för diagnosticering av cancer i vävnad SE0100197L (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE0100197A SE0100197L (sv) 2001-01-24 2001-01-24 Metod för diagnosticering av cancer i vävnad
PCT/SE2002/000116 WO2002059616A1 (en) 2001-01-24 2002-01-24 Method for cancer diagnostics
JP2002559682A JP2004529322A (ja) 2001-01-24 2002-01-24 がんの診断方法
CNA028040597A CN1502044A (zh) 2001-01-24 2002-01-24 癌症诊断方法
EP02716509A EP1354210B1 (en) 2001-01-24 2002-01-24 Method for cancer diagnostics
CA002435210A CA2435210A1 (en) 2001-01-24 2002-01-24 Method for cancer diagnostics
DE60216045T DE60216045T2 (de) 2001-01-24 2002-01-24 Krebsdiagnoseverfahren
AT02716509T ATE345503T1 (de) 2001-01-24 2002-01-24 Krebsdiagnoseverfahren
ES02716509T ES2276922T3 (es) 2001-01-24 2002-01-24 Metodo de diagnostico del cancer.
US10/466,908 US20040115746A1 (en) 2001-01-24 2002-01-24 Method for cancer diagnostic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0100197A SE0100197L (sv) 2001-01-24 2001-01-24 Metod för diagnosticering av cancer i vävnad

Publications (2)

Publication Number Publication Date
SE0100197D0 SE0100197D0 (sv) 2001-01-24
SE0100197L true SE0100197L (sv) 2002-07-25

Family

ID=20282710

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0100197A SE0100197L (sv) 2001-01-24 2001-01-24 Metod för diagnosticering av cancer i vävnad

Country Status (10)

Country Link
US (1) US20040115746A1 (sv)
EP (1) EP1354210B1 (sv)
JP (1) JP2004529322A (sv)
CN (1) CN1502044A (sv)
AT (1) ATE345503T1 (sv)
CA (1) CA2435210A1 (sv)
DE (1) DE60216045T2 (sv)
ES (1) ES2276922T3 (sv)
SE (1) SE0100197L (sv)
WO (1) WO2002059616A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101429540B (zh) * 2007-11-09 2013-07-10 北京雅康博生物科技有限公司 实时定量pcr检测细胞周期蛋白b2基因表达的方法
EP2943793A4 (en) * 2013-01-14 2016-08-24 Incelldx Inc PROCEDURE FOR A DECISION CONCERNING THE PERFORMANCE OF A TESTS OF A CROWN NECK CARTOON ON A NUTRITIONAL CANCER AND DEVICES AND KITS FOR THE IMPLEMENTATION OF THE PROCEDURE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543291A (en) * 1993-01-29 1996-08-06 Dana Farber Cancer Institute Method of detecting carcinoma

Also Published As

Publication number Publication date
JP2004529322A (ja) 2004-09-24
EP1354210A1 (en) 2003-10-22
CA2435210A1 (en) 2002-08-01
DE60216045T2 (de) 2007-07-05
WO2002059616A1 (en) 2002-08-01
ATE345503T1 (de) 2006-12-15
US20040115746A1 (en) 2004-06-17
DE60216045D1 (de) 2006-12-28
EP1354210B1 (en) 2006-11-15
SE0100197D0 (sv) 2001-01-24
ES2276922T3 (es) 2007-07-01
CN1502044A (zh) 2004-06-02

Similar Documents

Publication Publication Date Title
AU2001253079A1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
WO2002061128A3 (en) Method of determining a chemotherapeutic regimen based on ercc1 expression
TR200003903T2 (tr) Karsinomların erken teşhisi için yöntem
DK1975231T3 (da) Sammensætninger og fremgangsmåder til detektion, diagnose og terapi af hæmatologiske sygdomme
ATE238554T1 (de) Krebsbehandlung
CY1116265T1 (el) Kit ραδιοεπισημανσης και προσδιορισμος δεσμευσης
ATE449187T1 (de) Molekulare eigenschaften von nichtkleinzelligem lungenkrebs
DE69519796D1 (de) PTPalpha-Bestimmung in der Tumordiagnose und -Prognose
GB9827228D0 (en) Cancer detection method and reagents
ES2171219T3 (es) Deteccion precoz de cancer de prostata (cap) por determinacion de una relacion entre las concentraciones de antigeno especifico de prostata (psa) y calicreina glandular humana (hgk-1).
CA2284817A1 (en) Method for determining the presence of mutated brca protein
TR199902828T2 (xx) Lizofosfolipidlerin de�i�mi� konsantrasyonlar� ile birle�tirilmi� kanser belirleme y�ntemi.
GB2430740A (en) System and method for tracking and quatitating chemical entites
SE0100197L (sv) Metod för diagnosticering av cancer i vävnad
GB9710154D0 (en) Detection of retroviruses
TR200100175T2 (tr) Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler.
AU2003299352A8 (en) Method for analyzing tumor agressivity comprising measurement of polymerized actin
DE60328770D1 (de) Ein neuer biologischer tumormarker und methoden für die detektion des krebsartigen oder nicht krebsartigen phenotyps von zellen
WO2005045434A3 (en) Method for distinguishing aml subtypes with recurring genetic aberrations
Romas et al. Counterimmunoelectrophoretic studies of serum prostatic acid phosphatase
WO2002084284A3 (en) Diagnosis and treatment of cancer:ii
UA70269A (en) Method of the preoperational differential diagnosis of the benign and malignant tumors of the thyroid gland
陳守棟 et al. Sulfotransferase lAl is a Risk Factor for Breast Cancer in Young Women
UA31503A (uk) Спосіб визначення апоптозу в тестованих клітинах організму

Legal Events

Date Code Title Description
NAV Patent application has lapsed